Clinical Trials Sponsored by Pierre Fabre Portugal
Total 155 results
-
Pierre Fabre MedicamentIqvia Pty LtdRecruitingBreast Cancer | HER2-positive Breast Cancer | Adjuvant TherapyBelgium
-
University Hospital, LimogesPierre Fabre LaboratoriesCompleted
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
Pierre Fabre MedicamentIqvia Pty LtdRecruitingBRAF V600 Mutation | Metastatic Non-small Cell Lung CancerFrance
-
Pierre Fabre Pharma GmbHWinicker Norimed GmbHCompletedBreast Cancer | Non-Small-Cell Lung CancerGermany, Austria
-
Leiden University Medical CenterPierre Fabre LaboratoriesRecruitingMelanoma Stage III | In-Transit Metastasis of Cutaneous MelanomaNetherlands
-
Pierre Fabre MedicamentMerck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic Colorectal Cancer | BRAF V600EChina
-
Wales Cancer Trials UnitPierre Fabre LaboratoriesCompleted
-
University Hospital, Clermont-FerrandPierre Fabre LaboratoriesUnknownChronic Lymphocytic Leukemia | Lymphocytic LymphomaFrance
-
Fondazione Italiana Linfomi - ETSPierre Fabre Pharma AGNot yet recruiting
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
Pierre Fabre MedicamentEurotrials Brasil Consultores Cientificos LtdaWithdrawnVenous Disease Classification (CEAP): C2 or C3
-
Ludwig-Maximilians - University of MunichPierre Fabre LaboratoriesCompletedCarcinoma Breast Stage IVGermany
-
EspeRare FoundationIqvia Pty Ltd; Pierre Fabre MedicamentRecruitingX-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)United States, Spain, France, Germany, Italy, United Kingdom
-
PfizerOno Pharmaceutical Co. Ltd; Pierre Fabre LaboratoriesCompletedHealthyUnited States
-
Centre Hospitalier Universitaire de BesanconPierre Fabre MedicamentTerminated
-
Johannes Gutenberg University MainzPierre Fabre Pharma GmbHCompleted
-
SOLTI Breast Cancer Research GroupPierre Fabre LaboratoriesCompleted
-
Pierre Fabre Pharma GmbHDocCheck Medical Services GmbHCompleted
-
UNICANCERAstraZeneca; National Cancer Institute, France; Pierre Fabre LaboratoriesActive, not recruitingBreast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid TumoursFrance
-
Southern Europe New Drug OrganizationPierre Fabre Laboratories; AgennixUnknown
-
Grupo Español Multidisciplinar de MelanomaPierre Fabre Medicament; MFARActive, not recruitingMetastatic Melanoma | Brain MetastasesSpain
-
Pierre Fabre Dermo CosmetiqueUniversity Hospital, Geneva; University Paul Sabatier of Toulouse; Centre Européen... and other collaboratorsUnknown
-
Centre Oscar LambretNational Cancer Institute, France; Pierre Fabre LaboratoriesCompleted
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.CompletedTriple Negative Breast CancerSpain
-
Centre Hospitalier Universitaire de Saint EtiennePierre Fabre Dermo CosmetiqueTerminatedSkin Cancer | Skin AgingFrance
-
European Society for Blood and Marrow TransplantationPierre Fabre MedicamentTerminatedMyelodysplastic Syndromes | Secondary Acute Myeloid LeukemiaGermany, Italy, Netherlands, Russian Federation
-
Rennes University HospitalMinistry of Health, France; Pierre Fabre LaboratoriesCompletedMultiple Sclerosis | Urinary Tract Infections | Bladder DysfunctionFrance
-
Charite University, Berlin, GermanyBristol-Myers Squibb; Pierre Fabre Pharma GmbHUnknown
-
Spanish Breast Cancer Research GroupPierre Fabre Laboratories; Puma Biotechnology, Inc.RecruitingHER2 Positive Breast Cancer | Hormone Receptor Positive | Early-stage Breast CancerSpain
-
Federation Francophone de Cancerologie DigestiveMerck Sharp & Dohme LLC; Pierre Fabre LaboratoriesRecruitingColorectal Cancer | BRAF V600E Mutation PositiveFrance
-
Pierre Fabre MedicamentPfizer; Merck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdCompletedBRAF V600E-mutant Metastatic Colorectal CancerFrance, Italy, United States, Spain, United Kingdom, Belgium, Austria, Japan, Netherlands
-
CCTU- Cancer ThemePierre Fabre MedicamentNot yet recruitingMelanoma | CancerUnited Kingdom
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
Pierre Fabre MedicamentSGS Life Sciences, a division of SGS Belgium NVCompletedChronic Obstructive Pulmonary DiseaseBelgium, France
-
PfizerMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. Ltd; Pierre Fabre MedicamentCompletedBRAF V600E-mutant Metastatic Colorectal CancerUnited States, Spain, Korea, Republic of, United Kingdom, Australia, Czechia, Taiwan, Belgium, France, Hungary, Canada, Japan, Russian Federation, Netherlands, Israel, Germany, Turkey, Austria, Brazil, Poland, Italy, Argentina, Chile, Denmar... and more
-
Institut CurieHoffmann-La Roche; Ministry of Health, France; Amgen; Pierre Fabre LaboratoriesActive, not recruitingPrimary Central Nervous System LymphomaFrance
-
UNICANCERMerck Sharp & Dohme LLC; Pierre Fabre Medicament; European Association of Dermato...Active, not recruitingBrain Metastases | Malignant Melanoma | BRAF V600 MutationFrance
-
Soutien aux Actions contre les Maladies du Globule...Pierre Fabre Laboratories; ADDMEDICA SASARecruitingAcute Chest Syndrome | Vaso Occlusive CrisisFrance
-
University Hospital, BrestRoche Farma, S.A; Pierre Fabre Medicament; Groupe Français de Pneumo-CancérologieCompleted
-
AIO-Studien-gGmbHUniversitätsklinikum Hamburg-Eppendorf; Merck Serono GmbH, Germany; Pierre Fabre...RecruitingColorectal Cancer | Colon Cancer | BRAF V600 Mutation | BRAF V600E | Localized CancerGermany
-
Istituto Scientifico Romagnolo per lo Studio e...Pierre Fabre LaboratoriesTerminatedCarcinoma, Non-Small-Cell Lung | Secondary | Advanced Stage IIIB | High Thymidylate Synthase ExpressionItaly
-
Observatoire du Risque Infectieux en GériatrieMinistry of Health, France; Pierre Fabre Laboratories; Gaba LaboratoriesUnknown
-
Dr Anders UllénBayer; Pierre Fabre Laboratories; Nordic Urothelial Cancer Oncology GroupCompletedBladder Cancer | Urothelial Carcinoma | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerDenmark, Sweden
-
Intergroupe Francophone de Cancerologie ThoraciqueBristol-Myers Squibb; Pierre Fabre Laboratories; Ligue contre le cancer, FranceCompleted
-
Spanish Cooperative Group for the Treatment of...Merck, S.L., Spain; Pierre Fabre Ibérica, S.A.Not yet recruiting
-
Institut National de Recherche pour l'Agriculture...Hospital Avicenne; Adeprina; Institut de Recherche Pierre FabreCompletedOverweight | Hypertriglyceridemic WaistFrance
-
Institut National de Recherche pour l'Agriculture...Hospital Avicenne; Adeprina; Institut de Recherche Pierre FabreCompletedOverweight | Hypertriglyceridemic WaistFrance
-
Pierre Fabre Dermo CosmetiqueInstitut National de la Santé Et de la Recherche Médicale, France; Centre National...Completed
-
UNICANCEREli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead Sciences; Roche Pharma... and other collaboratorsRecruitingMetastatic Breast CancerFrance